Multi4 - the first surgical instrument for bladder cancer treatment through a 20-minute outpatient procedure

2026-07-22

Bladder Cancer (BC) is the most overlooked cancer type in terms of the development of new surgical tools aimed at achieving efficient cancer treatment. The instruments used in the operating room have remained unchanged since the 1960s. The standard of care involves a rigid metal cystoscope and a surgery under anaesthesia. The inherent risks to the patient are manifold, encompassing damage to the urethra, frictions, infections, and the potential reseeding of cancer cells elsewhere in the bladder. The lack of progress in this field is evident in the statistics: this cancer type has the highest recurrence rate of all cancers - up to 75%. In BC, approx. 60 % of healthcare costs are attributed to patient surveillance and treatment of recurrences. BC remains one of the most expensive cancers to manage and treat globally. Multi4, established by the experienced surgeon and women innovator Miden Melle-Hannah, is developing a ground-breaking surgical instrument that allows for effective treatment of BC in outpatient settings. This innovation transforms the patient's healthcare journey. Instead of the waiting period for difficult and hazardous surgeries, patients can now have their tumours removed directly in the urologist's office. This advancement is made possible through cutting-edge deep tech innovations in instrument engineering design. These innovations result in a surgical tool which integrates four functionalities (thus we call it “Multi4”): 1. Inject local anaesthesia through a thin needle; 2. Remove cancerous tissue using specially coated forceps; 3. Transport the cancer tissue out through the instrument itself; 4. Burn the area where the cancer was located to ensure the elimination of all cancer cells. This project will close the gap to market for Milti4 through clinical studies, transfer to production and certification according to MDR. The technology we propose is the first attempt since the 1960s to develop a new type of instrumentation for the treatment of BC.

Sweden

2025-10-15